Bal Pharma Ltd.

NSE: BALPHARMA | BSE: 524824

Mid-range Performer

96.43 4.11 (4.45%)

184.4K

NSE+BSE Volume

NSE 27 May, 2026 3:31 PM (IST)

Board Meeting

The latest board meeting for Bal Pharma took place on 27 May 2026, for the purpose of Audited Results, Final Dividend & ESOP See details

Bal Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents